Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
12.55
+1.21 (10.67%)
At close: Mar 9, 2026, 4:00 PM EDT
12.55
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:02 PM EDT
Benitec Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Market Capitalization | 429 | 307 | 65 | 7 | 9 | 33 | |
| Market Cap Growth | 58.00% | 369.05% | 881.17% | -29.60% | -71.60% | 294.06% | |
| Enterprise Value | 254 | 205 | 52 | 1 | 2 | 22 | |
| Last Close Price | 11.34 | 11.70 | 6.99 | 4.05 | 19.72 | 72.25 | |
| PS Ratio | - | - | - | 88.98 | 129.85 | 565.78 | |
| PB Ratio | 2.07 | 3.16 | 1.39 | 33.04 | 3.29 | 1.67 | |
| P/TBV Ratio | 2.36 | 3.16 | 1.39 | 33.04 | 3.29 | 1.67 | |
| EV/Sales Ratio | - | - | - | 9.94 | 23.51 | 367.04 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 2.77 | 0.28 | 0.01 | |
| Net Debt / Equity Ratio | -1.00 | -1.00 | -1.07 | -9.49 | -1.13 | -0.98 | |
| Net Debt / EBITDA Ratio | 3.89 | 2.32 | 2.26 | 0.10 | 0.18 | 1.46 | |
| Net Debt / FCF Ratio | 10.18 | 4.11 | 2.58 | 0.11 | 0.20 | 1.50 | |
| Asset Turnover | - | - | - | 0.01 | 0.01 | 0.00 | |
| Quick Ratio | 67.45 | 54.26 | 10.38 | 0.64 | 1.61 | 14.46 | |
| Current Ratio | 67.69 | 54.67 | 10.49 | 0.94 | 1.90 | 15.05 | |
| Return on Equity (ROE) | -33.50% | -52.46% | -91.68% | -1268.61% | -159.08% | -91.79% | |
| Return on Assets (ROA) | -22.41% | -34.39% | -49.60% | -228.53% | -81.59% | -51.55% | |
| Return on Capital Employed (ROCE) | -25.70% | -42.70% | -47.60% | -3926.10% | -518.90% | -67.90% | |
| Earnings Yield | -9.97% | -12.35% | -33.22% | -293.13% | -192.09% | -41.59% | |
| FCF Yield | -4.17% | -7.69% | -29.91% | -269.92% | -167.86% | -39.10% | |
| Buyback Yield / Dilution | -24.88% | -97.17% | -1225.17% | -188.30% | -90.24% | -320.63% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.